Statins, fibrates valuable in heart disease treatment - - Managed Healthcare Executive
Modern Medicine Network button
Statins, fibrates valuable in heart disease treatment


Managed Healthcare Executive


People with high cholesterol levels typically aren't ready to focus on the problem, and when they get a call from a case manager, they decline the program, he says. So an important aspect of the Sage plan is that members voluntarily sign up for it, and that means they are willing participants, he says.

Members are triaged into high-risk and low-risk groups. Health Net reaches out to members in the low risk group to encourage healthy behaviors, including appropriate use of statins. The high-risk group includes people who are experiencing significant problems such as angina, stroke, or heart attack. This group receives a comprehensive disease management program that includes counseling on co-morbid conditions as well as coronary artery disease.

Alere Medical Inc. provides the disease management services. Sage members show an increase in statin compliance from a baseline of 40% up to 55%, with an eventual goal of 70% compliance, Dr. Jacobs says.

This article is based on information supplied by The Medical Letter ( www.medicalletter.org), a non-profit organization offering critical appraisals of new drugs and comparative reviews of older drugs. The Medical Letter is independent of the pharmaceutical industry and supported by subscription sales. Institutional site license inquiries can be sent to info@medicalletter.org.

Elaine Zablocki has been reporting on healthcare for more than a dozen years, and serves as a member of Health Net of Oregon's Member Advisory Council.


post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.

ADVERTISEMENT

Managed Healthcare Executive Issue
Managed Healthcare Executive
Providing senior-level decision makers the comprehensive analysis, trends and strategies they need to innovate value in a rapidly changing healthcare landscape.

ADVERTISEMENT

2008 Leaders in Disease Managment
Source: Managed Healthcare Executive,
Click here